Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Barry Myers is a featured speaker at CED's MedTech 2008 Conference in Durham, NC
News | 03. 08. 2008
